进展|Abecma(ide-cel)欧盟获批四线治疗多发性骨髓瘤(MM)

Abecma(idecabtagenevicleucel,ide-cel)是首个靶向B细胞成熟抗原(BCMA) … 继续阅读进展|Abecma(ide-cel)欧盟获批四线治疗多发性骨髓瘤(MM)